Lakeshore Biopharma (LSB) Projected to Post Quarterly Earnings on Monday

Lakeshore Biopharma (NASDAQ:LSB) will likely be releasing its earnings data before the market opens on Monday, January 27th. Analysts expect Lakeshore Biopharma to post earnings of ($0.80) per share for the quarter.

Lakeshore Biopharma Trading Up 15.7 %

NASDAQ LSB opened at $2.72 on Monday. The company has a current ratio of 1.17, a quick ratio of 0.90 and a debt-to-equity ratio of 0.13. The stock’s 50-day simple moving average is $2.88. Lakeshore Biopharma has a twelve month low of $1.88 and a twelve month high of $11.20.

Lakeshore Biopharma Company Profile

LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.